New warnings for gadolinium-based contrast agents (GBCAs) …
FDA is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) concerning gadolinium remaining in...
Information on Gadolinium-Based Contrast Agents | FDA
Gadolinium-Based Contrast Agents (GBCA) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic …
MRI contrast agent - Wikipedia
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). [1] The most commonly used compounds for contrast …
Gadolinium Magnetic Resonance Imaging - StatPearls - NCBI Bookshelf
2023年7月3日 · Most MRI contrast agents are chelates of the rare-earth element gadolinium and produce an increased signal (“positive contrast”) on T1-weighted images (the effect on T2 …
MRI with Contrast (Gadolinium) Side Effects | UCSF Radiology
Gadolinium contrast agents help improve the quality of MRI scans. Side effects include nephrogenic systemic fibrosis (NSF) which is associated with the administration of intravenous …
Gadolinium Use in Breast Cancer MRIs: Benefits and Risks
2024年1月23日 · Gadolinium is the most commonly used contrast agent for MRI and the one that is used in imaging for the screening, diagnosis, or monitoring of breast cancer. Gadolinium's …
Update on Gadolinium-Based Contrast Agent Safety, From the
2023年10月18日 · Although extraordinarily safe, gadolinium-based contrast agents (GBCAs) may have side effects. Four distinct safety considerations include acute allergiclike reactions, …
Recent Advances in Gadolinium Based Contrast Agents for …
Gadolinium (Gd) based contrast agents (CAs) (Gd-CAs) represent one of the most advanced developments in the application of Gd for magnetic resonance imaging (MRI). Current …
A New Generation of Gadolinium-based MRI Contrast Agents: …
2023年7月18日 · Gadolinium-based contrast agents (GBCAs) are a critical component of the MRI examination for the assessment of pathologic and benign entities.
Gadolinium contrast agents- challenges and opportunities of a ...
Gadolinium-based contrast agent (GBCA) has been used since 1988 in MRI for diagnostic and follow-up of patients, the gadolinium good properties make it an effective choice for enhance …
- 某些结果已被删除